Noora Porkka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Noora Porkka has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Päivi Peltomäki
Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland
4 shared publications - Jukka-Pekka Mecklin
University of Jyväskylä 1 Gerontology Research Center and Faculty of Sport and Health Sciences Jyväskylä, Finland
3 shared publications - Samuli Eldfors
Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland
3 shared publications - Alisa Olkinuora
Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland
2 shared publications - Taina Tuulikki Nieminen
Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland
2 shared publications Teijo Kuopio
Department of Pathology, Jyväskylä Central Hospital, Jyväskylä, Finland
2 shared publications
Latest Publications
- Open Access
- 7 April 2020
- Published by Impact Journals, LLC in Oncotarget
- Vol. 11 (14) , 1244-1256
Does breast carcinoma belong to the Lynch syndrome tumor spectrum? – Somatic mutational profiles vs. ovarian and colorectal carcinomas
Https://doi.org/10.18632/oncotarget.27538 Noora K. Porkka, Alisa Olkinuora, Teijo Kuopio, Maarit Ahtiainen, Samuli Eldfors, Henrikki Almusa, Jukka-Pekka Mecklin, Päivi Peltomäki
- 7 April 2020
- Published by Impact Journals, LLC in Oncotarget
- Vol. 11 (14) , 1244-1256
Open AccessDoes breast carcinoma belong to the Lynch syndrome tumor spectrum? – Somatic mutational profiles vs. ovarian and colorectal carcinomas
Https://doi.org/10.18632/oncotarget.27538 Noora K. Porkka, Alisa Olkinuora, Teijo Kuopio, Maarit Ahtiainen, Samuli Eldfors, Henrikki Almusa, Jukka-Pekka Mecklin, Päivi Peltomäki
- Open Access
- 21 December 2018
- Published by Wiley in International Journal of Cancer
- Vol. 145 (1) , 87-98
Epidemiological, clinical and molecular characterization of Lynch‐like syndrome: A population‐based study
Colorectal carcinomas that are mismatch repair (MMR)‐deficient in the absence of MLH1 promoter methylation or germline mutations represent Lynch‐like syndrome (LLS). Double somatic events inactivating MMR genes are involved in the etiology of LLS tumors. Our purpose was to define the clinical and broader molecular hallmarks of LLS tumors and the population incidence of LLS, which remain poorly characterized. We investigated 762 consecutive colorectal carcinomas operated in Central Finland in 2000–2010. LLS cases were identified by a stepwise protocol based on MMR protein expression, MLH1 methylation and MMR gene mutation status. LLS tumors were profiled for CpG Island Methylator Phenotype (CIMP) and somatic mutations in 578 cancer‐relevant genes. Among 107 MMR‐deficient tumors, 81 (76%) were attributable to MLH1 promoter methylation and 9 (8%) to germline mutations (Lynch syndrome, LS), leaving 14 LLS cases (13%) (3 remained unclassified). LLS carcinomas were diagnosed at a mean age of 65 years (vs. 44 years in LS, p < 0.001), had a proximal to distal ratio of 1:1, and all were BRAF V600E‐negative. Two somatic events in MMR genes were identifiable in 11 tumors (79%). As novel findings, the tumors contained an average of 31 nonsynonymous somatic mutations/Mb and 13/14 were CIMP‐positive. In conclusion, we establish the epidemiological, clinical and molecular characteristics of LLS in a population‐based study design. Significantly more frequent CIMP‐positivity and lower rates of somatic mutations make a distinction to LS. The absence of BRAF V600E mutation separates LLS colorectal carcinomas from MLH1‐methylated colorectal carcinomas with CIMP‐positive phenotype.
- 21 December 2018
- Published by Wiley in International Journal of Cancer
- Vol. 145 (1) , 87-98
Open AccessEpidemiological, clinical and molecular characterization of Lynch‐like syndrome: A population‐based study
Colorectal carcinomas that are mismatch repair (MMR)‐deficient in the absence of MLH1 promoter methylation or germline mutations represent Lynch‐like syndrome (LLS). Double somatic events inactivating MMR genes are involved in the etiology of LLS tumors. Our purpose was to define the clinical and broader molecular hallmarks of LLS tumors and the population incidence of LLS, which remain poorly characterized. We investigated 762 consecutive colorectal carcinomas operated in Central Finland in 2000–2010. LLS cases were identified by a stepwise protocol based on MMR protein expression, MLH1 methylation and MMR gene mutation status. LLS tumors were profiled for CpG Island Methylator Phenotype (CIMP) and somatic mutations in 578 cancer‐relevant genes. Among 107 MMR‐deficient tumors, 81 (76%) were attributable to MLH1 promoter methylation and 9 (8%) to germline mutations (Lynch syndrome, LS), leaving 14 LLS cases (13%) (3 remained unclassified). LLS carcinomas were diagnosed at a mean age of 65 years (vs. 44 years in LS, p < 0.001), had a proximal to distal ratio of 1:1, and all were BRAF V600E‐negative. Two somatic events in MMR genes were identifiable in 11 tumors (79%). As novel findings, the tumors contained an average of 31 nonsynonymous somatic mutations/Mb and 13/14 were CIMP‐positive. In conclusion, we establish the epidemiological, clinical and molecular characteristics of LLS in a population‐based study design. Significantly more frequent CIMP‐positivity and lower rates of somatic mutations make a distinction to LS. The absence of BRAF V600E mutation separates LLS colorectal carcinomas from MLH1‐methylated colorectal carcinomas with CIMP‐positive phenotype.
- Open Access
- 1 July 2018
- Published by Elsevier in Gynecologic Oncology
- Vol. 150 (1) , 92-98
Converging endometrial and ovarian tumorigenesis in Lynch syndrome: Shared origin of synchronous carcinomas
- 1 July 2018
- Published by Elsevier in Gynecologic Oncology
- Vol. 150 (1) , 92-98
Open AccessConverging endometrial and ovarian tumorigenesis in Lynch syndrome: Shared origin of synchronous carcinomas
- Open Access
- 14 November 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (64) , 108020-108030
Sequencing of Lynch syndrome tumors reveals the importance of epigenetic alterations
Sequencing of Lynch syndrome tumors reveals the importance of epigenetic alterations Sequencing of Lynch syndrome tumors reveals the importance of epigenetic alterations
- 14 November 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (64) , 108020-108030
Open AccessSequencing of Lynch syndrome tumors reveals the importance of epigenetic alterations
Sequencing of Lynch syndrome tumors reveals the importance of epigenetic alterations Sequencing of Lynch syndrome tumors reveals the importance of epigenetic alterations
- Open Access
- 23 September 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (43) , 70685-70698
Pseudoexons provide a mechanism for allele-specific expression of APC in familial adenomatous polyposis
Pseudoexons provide a mechanism for allele-specific expression of APC in familial adenomatous polyposis
- 23 September 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (43) , 70685-70698
Open AccessPseudoexons provide a mechanism for allele-specific expression of APC in familial adenomatous polyposis
Pseudoexons provide a mechanism for allele-specific expression of APC in familial adenomatous polyposis